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  Abstract 
Photothermal therapy is a new method for cancer therapy, which has special 
advantages over traditional cancer treatments, such as minimal invasiveness, short 
recovery times and few complication rates. And the combination of photothermal 
therapy and chemotherapy in one system is a more effective way to destroy cancer 
cells than monotherapy since it can deliver both heat and drug simultaneously to the 
tumor.  
Graphene, a two-dimensional carbon nanomaterial, has ultrahigh specific surface 
area and strong NIR absorbance, which has great potential in drug delivery and 
photothermal therapy. However, in the current study, graphene suffers from only 
loading hydrophobic drug by π-π stacking and hydrophobic interactions, failing to 
load hydrophilic drug due to lack of interactions, and not providing drug protection 
from inactivation in biological environments. Dopamine (DA), containing both 
catechol and amine functional groups, can undergo self-polymerization to form 
polydopamine (PDA), which can adhere on a wide range of substrates in mild 
polymerization conditions. In addition, PDA shows excellent biocompatiblity and 
photothermal performance. These attributes make PDA promising for drug delivery 
and photothermal therapy in cancer. 
Herein, we present a facial method to develop a versatile drug delivery 
nanoplatform, polydopamine functionalized graphene oxide (rGO-PDA), based on 
graphene oxide (GO) and dopamine (DA), which can be used for the combined 
chemotherapy and photothermal therapy. In the process of fabricating the 
nanoplatform, GO was reduced to reduced graphene oxide (rGO) by dopamine (DA) 
and coated by polydopamine (PDA) through the self-polymerization of DA, and in the 
meantime, drug was encapsulated inside the PDA coating layer and rGO. Besides 
achieving encapsulation of both hydrophilic and hydrophobic drugs and providing 
protection, PDA-functionalized GO (rGO-PDA) nanocomposite exhibits excellent 
photothermal performance, high drug loading capacity, good biocompatibility, 
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vitro release study indicated that the NIR laser irradiation could accelerate the release 
of loaded drugs from rGO-PDA. These features mentioned above make the rGO-PDA 
nanocomposite achieving the excellent in vitro and in vivo synergistic antitumor effect. 
Our work encourages further exploration of versatile nanoplatform for cancer therapy. 
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第一章  绪论 
1.1 前言 
肿瘤极大地威胁着人类的健康与生命，目前已成为人类死亡的主要因素之一。
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热治疗肿瘤。戴宏杰课题组[24]用分别接枝了 DSPE 和 C18-PMH 的聚乙二醇
（DSPE-mPEG、C18-PMH-mPEG）修饰单壁碳纳米管（SWCNTs），得到了水溶
性的 PEGylated SWCNTs，并在小鼠体内表现出良好的光热消融肿瘤效果。 
金纳米结构材料，包括金纳米壳、金纳米棒、金纳米笼和金纳米颗粒等，具
有良好的生物相容性和优异的光热性能，能够吸收近红外光并有效地将光能转换
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